|
TMEM38B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.384000E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.189400E-04 |
| Normal-vs-Stage2 |
7.181200E-01 |
| Normal-vs-Stage3 |
3.143000E-03 |
| Normal-vs-Stage4 |
3.7687000000064E-05 |
| Stage1-vs-Stage2 |
1.469970E-02 |
| Stage1-vs-Stage3 |
9.757200E-01 |
| Stage1-vs-Stage4 |
1.098030E-01 |
| Stage2-vs-Stage3 |
1.423580E-02 |
| Stage2-vs-Stage4 |
1.724690E-03 |
| Stage3-vs-Stage4 |
1.650400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.36419999999349E-05 |
| Normal-vs-AfricanAmerican |
2.948000E-02 |
| Normal-vs-Asian |
2.788100E-04 |
| Caucasian-vs-AfricanAmerican |
6.576400E-01 |
| Caucasian-vs-Asian |
5.133800E-01 |
| AfricanAmerican-vs-Asian |
3.756400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.617300E-04 |
| Normal-vs-Female |
1.215640E-03 |
| Male-vs-Female |
2.875600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.85429999999665E-05 |
| Normal-vs-Age(41-60Yrs) |
3.256300E-03 |
| Normal-vs-Age(61-80Yrs) |
1.393400E-01 |
| Normal-vs-Age(81-100Yrs) |
5.832400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.044200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.422150E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.818800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.272400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.587400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.927400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.439580E-03 |
| Classical-VS-Follicular |
6.42469999978523E-07 |
| Classical-VS-Other |
2.537400E-01 |
| Classical-VS-Normal |
1.53373999999262E-05 |
| Tall-VS-Follicular |
4.49720038986356E-10 |
| Tall-VS-Other |
7.475000E-01 |
| Tall-VS-Normal |
1.55760004894034E-09 |
| Follicular-VS-Other |
3.639200E-04 |
| Follicular-VS-Normal |
1.231220E-01 |
| Other-VS-Normal |
1.635340E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.849900E-02 |
| Normal-vs-N1 |
4.13509999575012E-08 |
| N0-vs-N1 |
2.03549999999719E-05 |
|
|
